생물 지표 시장 규모, 점유율, 성장률 및 세계 업계 분석, 지역별 동향, 예측(2026-2034년)

Growth Factors of biological indicators Market

The global biological indicators market was valued at USD 834.2 million in 2025 and is projected to grow from USD 871.49 million in 2026 to USD 1,296.47 million by 2034, registering a CAGR of 5.09% during the forecast period (2026-2034). North America dominated the global market with a 49.02% market share in 2025, supported by advanced healthcare infrastructure, stringent sterilization standards, and increasing demand for infection prevention solutions.

Biological indicators (BIs) are sterilization monitoring tools containing viable microorganisms with defined resistance to specific sterilization processes. They are widely used to validate the effectiveness of steam, hydrogen peroxide, ethylene oxide, and other sterilization methods in hospitals, pharmaceutical manufacturing, medical device production, and research laboratories. Rising concerns regarding hospital-acquired infections (HAIs), strict regulatory compliance, and growing healthcare investments are accelerating market demand. Moreover, manufacturers continue introducing advanced rapid biological indicators that improve sterilization validation while reducing turnaround time.

The COVID-19 pandemic significantly increased awareness regarding infection prevention and sterilization protocols across healthcare facilities. Post-pandemic investments in hospital sterilization infrastructure and medical device manufacturing continue to support long-term market expansion.

Latest Market Trends

One of the most prominent trends in the biological indicators market is the increasing launch of advanced sterilization monitoring products by leading manufacturers. Companies are introducing rapid biological indicators capable of delivering faster sterilization validation, helping hospitals release sterilized instruments more quickly while maintaining patient safety.

Another important trend is the growing outsourcing of sterilization services by hospitals, pharmaceutical companies, and medical device manufacturers. Third-party sterilization service providers are expanding globally to offer cost-effective and specialized sterilization solutions, increasing the adoption of biological indicators across healthcare and industrial facilities.

Market Drivers

The growing number of hospital admissions and increasing prevalence of hospital-acquired infections remain primary drivers of market growth. Rising incidences of surgical site infections, bloodstream infections, urinary tract infections, and other healthcare-associated infections have increased the need for validated sterilization processes. Biological indicators play a critical role in confirming that sterilization cycles effectively eliminate harmful microorganisms, ensuring patient safety and regulatory compliance.

Another major growth factor is the expansion of pharmaceutical and medical device manufacturing worldwide. Developing countries are investing heavily in healthcare production facilities, creating strong demand for sterilization validation products throughout manufacturing operations. In addition, increasing awareness among healthcare professionals regarding infection prevention continues to support product adoption across hospitals, clinics, and laboratories.

Market Restraints

Despite growing adoption, the market faces challenges due to frequent product recalls associated with sterilization indicators. Quality-related issues affecting biological indicators can reduce customer confidence, damage manufacturer reputations, and temporarily slow product adoption.

Additionally, the relatively high cost of biological indicators compared with chemical indicators limits adoption, particularly in low- and middle-income countries. Budget constraints encourage healthcare providers to use lower-cost sterilization monitoring alternatives, restricting market penetration in price-sensitive regions.

Market Segmentation

Based on product, steam biological indicators dominated the market in 2026 owing to their extensive use in steam sterilization systems and continuous product innovation by leading manufacturers. Hydrogen peroxide biological indicators are projected to witness the fastest growth due to increasing regulatory approvals and expanding adoption of vaporized hydrogen peroxide sterilization technologies.

By form, self-contained vials accounted for the largest market share in 2026 because they provide rapid, reliable, and highly visible sterilization results. Their convenience and ease of use have made them the preferred choice across healthcare facilities.

Based on type, rapid biological indicators dominated the market in 2026 due to their ability to provide sterilization validation within minutes, significantly improving workflow efficiency compared to conventional biological indicators.

By sterilization method, steam sterilization remained the leading segment owing to its widespread use in hospitals and surgical centers. Meanwhile, hydrogen peroxide sterilization is expected to record the fastest growth through 2034 as healthcare providers increasingly adopt safer and more efficient sterilization technologies.

Based on end-user, hospitals & clinics held the largest market share due to increasing surgical procedures, rising healthcare-associated infections, and growing investments in advanced sterilization infrastructure. Pharmaceutical and medical device manufacturers continue to represent another important customer segment driven by stringent regulatory sterilization requirements.

Regional Outlook

North America generated USD 310.84 million in 2025 and is projected to reach USD 324.81 million in 2026. The region benefits from advanced healthcare systems, high awareness of infection prevention, strict sterilization regulations, and the strong presence of leading manufacturers.

Europe recorded USD 235.54 million in 2025 and is expected to reach USD 246.06 million in 2026. Growing participation of manufacturers in medical conferences, increasing awareness among healthcare professionals, and expanding sterilization practices continue to support regional growth.

Asia Pacific reached USD 215.27 million in 2025 and is forecast to grow to USD 225.73 million in 2026. Rapid healthcare infrastructure development, increasing medical device production, and continuous product launches are driving market expansion across China, Japan, India, and Southeast Asia.

Latin America and the Middle East & Africa are expected to experience steady growth as awareness regarding sterilization monitoring increases and healthcare investments continue to improve across emerging economies.

Key Companies

Major companies operating in the biological indicators market include STERIS, Getinge, ASP (Fortive), Solventum, Terragene, Mesa Labs, Inc., Tuttnauer, LISTER BIOMEDICAL CO., LTD, BEYA Medical Machine Equipments CO., and Propper Manufacturing Co., Inc. These companies continue strengthening their market position through product innovation, acquisitions, strategic partnerships, facility expansion, and participation in international healthcare exhibitions.

Conclusion

The biological indicators market is expected to witness steady growth from 2026 to 2034, driven by increasing hospital admissions, rising healthcare-associated infections, expansion of pharmaceutical and medical device manufacturing, and stricter sterilization regulations worldwide. Continuous technological advancements, growing adoption of rapid biological indicators, and expanding sterilization infrastructure across both developed and emerging markets will continue creating significant opportunities for industry participants.

Segmentation By Product

• Steam Biological Indicators
• Hydrogen Peroxide Biological Indicators
• Others

By Form

• Self-contained Vials
• Indicator Strips
• Others

By Type

• Traditional Biological Indicators
• Rapid Biological Indicators

By Sterilization Method

• Steam Sterilization
• Hydrogen Peroxide Sterilization
• Ethylene Oxide Sterilization
• Others

By End-user

• Hospital & Clinics
• Pharmaceutical & Medical Device Manufacturers
• Others

By Region

• North America (By Product, By Form, By Type, By Sterilization Method, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Product, By Form, By Type, By Sterilization Method, By End-user, and By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product, By Form, By Type, By Sterilization Method, By End-user, and By Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product, By Form, By Type, By Sterilization Method, By End-user, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product, By Form, By Type, By Sterilization Method, By End-user, and By Country/Sub-Region)
  • GCC
  • South Africa
• Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Incidence of Hospital Acquired Infections - by Key Countries/Sub-regions, 2025
• 4.2. New Product Launches - by Key Players
• 4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)

5. Global Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Steam Biological Indicators
  • 5.1.2. Hydrogen Peroxide Biological Indicators
  • 5.1.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Form
  • 5.2.1. Self-contained Vials
  • 5.2.2. Indicator Strips
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Type
  • 5.3.1. Traditional Biological Indicators
  • 5.3.2. Rapid Biological Indicators
• 5.4. Market Analysis, Insights and Forecast - By Sterilization Method
  • 5.4.1. Steam Sterilization
  • 5.4.2. Hydrogen Peroxide Sterilization
  • 5.4.3. Ethylene Oxide Sterilization
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By End-user
  • 5.5.1. Hospital & Clinics
  • 5.5.2. Pharmaceutical & Medical Device Manufacturers
  • 5.5.3. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Steam Biological Indicators
  • 6.1.2. Hydrogen Peroxide Biological Indicators
  • 6.1.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Form
  • 6.2.1. Self-contained Vials
  • 6.2.2. Indicator Strips
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Type
  • 6.3.1. Traditional Biological Indicators
  • 6.3.2. Rapid Biological Indicators
• 6.4. Market Analysis, Insights and Forecast - By Sterilization Method
  • 6.4.1. Steam Sterilization
  • 6.4.2. Hydrogen Peroxide Sterilization
  • 6.4.3. Ethylene Oxide Sterilization
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By End-user
  • 6.5.1. Hospital & Clinics
  • 6.5.2. Pharmaceutical & Medical Device Manufacturers
  • 6.5.3. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Steam Biological Indicators
  • 7.1.2. Hydrogen Peroxide Biological Indicators
  • 7.1.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Form
  • 7.2.1. Self-contained Vials
  • 7.2.2. Indicator Strips
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Type
  • 7.3.1. Traditional Biological Indicators
  • 7.3.2. Rapid Biological Indicators
• 7.4. Market Analysis, Insights and Forecast - By Sterilization Method
  • 7.4.1. Steam Sterilization
  • 7.4.2. Hydrogen Peroxide Sterilization
  • 7.4.3. Ethylene Oxide Sterilization
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By End-user
  • 7.5.1. Hospital & Clinics
  • 7.5.2. Pharmaceutical & Medical Device Manufacturers
  • 7.5.3. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.6.1. Germany
  • 7.6.2. U.K.
  • 7.6.3. France
  • 7.6.4. Italy
  • 7.6.5. Spain
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia Pacific Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Steam Biological Indicators
  • 8.1.2. Hydrogen Peroxide Biological Indicators
  • 8.1.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Form
  • 8.2.1. Self-contained Vials
  • 8.2.2. Indicator Strips
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Type
  • 8.3.1. Traditional Biological Indicators
  • 8.3.2. Rapid Biological Indicators
• 8.4. Market Analysis, Insights and Forecast - By Sterilization Method
  • 8.4.1. Steam Sterilization
  • 8.4.2. Hydrogen Peroxide Sterilization
  • 8.4.3. Ethylene Oxide Sterilization
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By End-user
  • 8.5.1. Hospital & Clinics
  • 8.5.2. Pharmaceutical & Medical Device Manufacturers
  • 8.5.3. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. Australia
  • 8.6.5. Southeast Asia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Steam Biological Indicators
  • 9.1.2. Hydrogen Peroxide Biological Indicators
  • 9.1.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Form
  • 9.2.1. Self-contained Vials
  • 9.2.2. Indicator Strips
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Type
  • 9.3.1. Traditional Biological Indicators
  • 9.3.2. Rapid Biological Indicators
• 9.4. Market Analysis, Insights and Forecast - By Sterilization Method
  • 9.4.1. Steam Sterilization
  • 9.4.2. Hydrogen Peroxide Sterilization
  • 9.4.3. Ethylene Oxide Sterilization
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By End-user
  • 9.5.1. Hospital & Clinics
  • 9.5.2. Pharmaceutical & Medical Device Manufacturers
  • 9.5.3. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Biological Indicators Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Steam Biological Indicators
  • 10.1.2. Hydrogen Peroxide Biological Indicators
  • 10.1.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Form
  • 10.2.1. Self-contained Vials
  • 10.2.2. Indicator Strips
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Type
  • 10.3.1. Traditional Biological Indicators
  • 10.3.2. Rapid Biological Indicators
• 10.4. Market Analysis, Insights and Forecast - By Sterilization Method
  • 10.4.1. Steam Sterilization
  • 10.4.2. Hydrogen Peroxide Sterilization
  • 10.4.3. Ethylene Oxide Sterilization
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By End-user
  • 10.5.1. Hospital & Clinics
  • 10.5.2. Pharmaceutical & Medical Device Manufacturers
  • 10.5.3. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.6.1. South Africa
  • 10.6.2. GCC
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. STERIS
    • 11.2.1.1. Overview
    • 11.2.1.2. Products
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Getinge
    • 11.2.2.1. Overview
    • 11.2.2.2. Products
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. ASP (Fortive)
    • 11.2.3.1. Overview
    • 11.2.3.2. Products
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Solventum
    • 11.2.4.1. Overview
    • 11.2.4.2. Products
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Terragene
    • 11.2.5.1. Overview
    • 11.2.5.2. Products
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Mesa Labs, Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Tuttnauer
    • 11.2.7.1. Overview
    • 11.2.7.2. Products
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. LISTER BIOMEDICAL CO., LTD
    • 11.2.8.1. Overview
    • 11.2.8.2. Products
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. BEYA Medical Machinery Equipments CO.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Propper Manufacturing Co., Inc.
    • 11.2.10.1. Overview
    • 11.2.10.2. Products
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)